Covid-19 diagnosis. Covid Shield+ also carves out a new niche product category for the industry, which caters to people’s increased protection needs, arising because of the pandemic.
This insurance product carries term cover for a 1-year tenure and also offers a critical illness benefit.“We have always strived to create relevant innovation, in line with the changing customer needs.
Through our recent customer interactions, we realised that the threat of financial impact, has made this disease even more daunting.
People are worried that a Covid-19 diagnosis will disrupt their savings and therefore their long-term aspirations. We want to take away that worry from our customers through Covid Shield+ and let them focus on a healthy recovery.